about
Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?Nicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A ReviewPathologic cellular events in smoking-related pancreatitisNicotine-mediated cell proliferation and tumor progression in smoking-related cancersIndividual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPDCigarette smoke-induced pancreatic damage: experimental data.Quantitation of pyridylhydroxybutyl-DNA adducts in liver and lung of F-344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.Prevention of pancreatic cancer by the beta-blocker propranolol.Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells.Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells.Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension.Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN.Acetylcholine receptor pathway in lung cancer: New twists to an old story.Cloning and characterization of a hybridoma secreting a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-specific monoclonal antibody and recombinant F(ab)CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.Smoking and Pancreatic DiseaseFrom smoking to cancers: novel targets to neuronal nicotinic acetylcholine receptors.CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells: effects on motility, migration and p63 expression.Functional characterization of the α5(Asn398) variant associated with risk for nicotine dependence in the α3β4α5 nicotinic receptor.The emerging role of smoking in the development of pancreatitis.Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma.Epidemiologic and Mechanistic Associations Between Smoking and Pancreatitis.Tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone initiates and enhances pancreatitis responsesDevelopment and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.Inhibition of pancreatic acinar mitochondrial thiamin pyrophosphate uptake by the cigarette smoke component 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid.The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells.Neurotransmitter receptors as central regulators of pancreatic cancerGABA (γ-aminobutyric acid), a non-protein amino acid counters the β-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: a review of experimental evidence.Role of autophagy in head and neck cancer and therapeutic resistance.The Role of Nitrosamine (NNK) in Breast Cancer Carcinogenesis.New Trends in Cancer Therapy: Targeting Ion Channels and Transporters.Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma.NNK enhances cell migration through α7-nicotinic acetylcholine receptor accompanied by increased of fibronectin expression in gastric cancer.Nicotinic acetylcholine receptors mediate lung cancer growth.The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema.Agonist and antagonist effects of tobacco-related nitrosamines on human α4β2 nicotinic acetylcholine receptors.
P2860
Q26748741-273A3422-0E11-4CE7-AEA6-D5802B2F1C85Q26784043-98D01A17-2DEA-4217-8AA1-2F52D1C8BAA8Q26864475-1502F639-6D5D-4946-A7F7-70F8D495AE69Q28395572-6377AB01-4253-4178-B0ED-C904ACC8FBA3Q28743099-8FC7801D-9887-468C-BD9E-EB60F09FCF99Q31142695-035C1660-A827-41DA-AA09-DD946E53B458Q31159988-FB344251-2C4A-4022-A4BB-7F2BF098F82DQ33433895-B369BF42-EE82-4230-AAD1-F643D7AC62CDQ33669976-43D9EC67-3498-427D-9B0B-69B40C8CA4C9Q33720833-0BE6D673-38E5-4455-BFBB-D040A172E79EQ33815657-5F828809-A2D5-4550-835F-52A386E2E7B7Q33820316-B538E6ED-52CC-434B-AD34-9A2B36A074EEQ34031242-89CF25D6-5136-4AA8-B4CE-C43E83FCD77BQ34334569-4D107D8E-1F4D-4C98-BF24-875DB45C7CE6Q34471921-F05AD3A4-9ACA-47D8-A26E-B30CB1218858Q34660601-F58F3986-075B-437A-9E31-34504D70683DQ35104827-F7204E2E-3BF2-4C2C-A651-6CAEB1C34B32Q35190782-58A74AF3-8699-4BB9-9CFF-69F5F8F21474Q35415808-367AB1C3-5D93-48ED-8128-69FA6A6020F8Q35567425-8F6CBFD1-0336-4F09-82F6-2672B56B3779Q35619485-B47AA4D4-FBD6-49EE-BE09-7D4ED2D787A9Q35940014-CED2E9FF-A778-4FF0-9ACE-0ABF09E40BACQ36309502-999EFE96-E310-4D01-BC3F-E741BD9C00A4Q36826807-2292858C-8EC5-4333-A86D-E35CAA22DAF6Q36955300-03157B46-C93A-42F5-820F-39CB54BE1D34Q37019298-9B598D41-7F21-4771-9680-304C09002C2CQ37240535-E5D1288A-C34D-4E0E-BC10-47E14DD5BBAEQ37289008-CFDE2CBA-9724-4C8E-A951-AA5C119066F6Q37292726-7D055E88-4366-4FAE-8EBB-DA8EEC35D6F1Q37315146-9C52E750-50EB-44D3-8D59-1CD09EFBD051Q37690295-841C5BB9-D754-4778-A607-35E2B568F88BQ37909261-36FA5CC3-01C9-4A37-BB8F-A4A3DFD8472FQ38209432-842CA830-CC6C-4877-9D93-70DD1B798380Q38664710-A5ABA678-1481-43DD-8D7A-BE24B7D39815Q38974256-8B747F1B-933A-4618-8FAB-8B4A256D936AQ38978893-1158D07A-A635-404E-B010-9D6C03CA2B16Q39463677-EA28FA78-8EB7-42EE-8D9A-5A9914AADAF7Q42010774-980A38BE-9982-4AA6-922F-72681EB91CACQ43223136-9C7277D4-0ED8-448C-802D-5ECA91D0B1F1Q43238547-9778A01E-F9F9-4531-B5B6-5C154D45589E
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nitrosamines as nicotinic receptor ligands
@ast
Nitrosamines as nicotinic receptor ligands
@en
type
label
Nitrosamines as nicotinic receptor ligands
@ast
Nitrosamines as nicotinic receptor ligands
@en
prefLabel
Nitrosamines as nicotinic receptor ligands
@ast
Nitrosamines as nicotinic receptor ligands
@en
P2860
P1433
P1476
Nitrosamines as nicotinic receptor ligands
@en
P2093
Hildegard M Schuller
P2860
P304
P356
10.1016/J.LFS.2007.03.006
P407
P577
2007-03-19T00:00:00Z